Showing results (31-40 of 12,394) with videos related to
Sort By:
Pageof 1,240
Investigational New Drugs|September 1, 1988
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapyM McCabe, F P Smith, J S Macdonald, et al.Cancer Research|October 1, 1981
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosoureaP V Woolley, P V Luc, A Rahman, et al.Cancer Research|April 1, 1988
Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogueA Rahman, J K Roh, M K Wolpert-DeFilippes, et al.Cancer Treatment Reports|October 1, 1980
Phase I clinical trial of spirogermaniumP S Schein, M Slavik, T Smythe, et al.Cancer Treatment Reports|December 1, 1985
Phase I study of echinomycin administered on an intermittent bolus scheduleJ H Harvey, M McFadden, W G Andrews, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1983
Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future managementF P Smith, D Stablein, S Korsmeyer, et al.Blood|October 1, 1978
Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancerR G Wiggans, R J Jacobson, P J Fialkow, et al.Cancer|April 1, 1979
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for adenocarcinoma of the lungT P Butler, J S MacDonald, F P Smith, et al.Cancer Chemotherapy and Pharmacology|January 1, 1980
Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusionJ J Gullo, C L Litterst, P J Maguire, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1990
A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicinA Rahman, J Treat, J K Roh, et al.Pageof 1,240